News

First investments of AMR Action Fund

The AMR Action Fund has announced its first investment to fulfill its aim to bring two to four new antibiotics to market. The fund will provide for research in Adaptive Phagte Therapeutics (APT) and Venatorx Pharmaceuticals.

Read More...

2021 Antimicrobial Resistance Benchmark report

The third AMR Benchmark is an independent report that compares and analyses how pharmaceutical companies are responding to the crisis of antimicrobial resistance.

Read More...

Join the next GARDP AMR discussion 19th November

This World Antimicrobial awareness week, GARDP, together with WHO, will be holding an AMR Discussions webinar. A panel will discuss the roles that different actors can play in the development of new antibiotics.

Read More...

Media-attention for AMR: “Create anti-bodies to strengthen bodies’ defences.”

For the Dutch radio program at NPO radio 1, Suzan Rooijakkers, explains how Antimicrobial Resistance (AMR) continues to threaten our abilities to treat common infections.

Read More...

Horizon Europe launched with a budget of €95.5 billion

Horizon Europe, EU’s key funding programme for research and innovation, has just been launched with a budget of €95.5 billion.

Read More...

G7 Health Ministers meet to discuss improved collaboration after COVID-19

The G7 group of nations met in the UK on June 11-13, and discussed on helping the world fight and then build back better from coronavirus and create a greener, more prosperous future.

Read More...